Targeting of mTOR is associated with decreased growth and decreased VEGF expression in acute myeloid leukaemia cells.
Böhm A, Aichberger KJ, Mayerhofer M, Herrmann H, Florian S, Krauth MT, Derdak S, Samorapoompichit P, Sonneck K, Vales A, Gleixner KV, Pickl WF, Sperr WR, Valent P.
Böhm A, et al. Among authors: mayerhofer m.
Eur J Clin Invest. 2009 May;39(5):395-405. doi: 10.1111/j.1365-2362.2009.02101.x.
Eur J Clin Invest. 2009.
PMID: 19320940